NCT04303702 The Role of Oxytocin in the Second Stage of Labor
| NCT ID | NCT04303702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Labor Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2022-07-01 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2022-07-01 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.
Eligibility Criteria
Inclusion Criteria: * Nulliparous pregnant women \>/= 37 weeks gestation * Singleton pregnancies * Admission for induction of labor or spontaneous labor Exclusion Criteria: * Multiple gestations * Multiparous patients * Patients with major fetal anomalies * Not on oxytocin at the time of complete cervical dilation * Patients with fetal head visible at the perineum on diagnosis of complete cervical dilation * Maternal medical condition that prohibits prolonged second stage
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04303702 clinical trial?
This trial is open to female participants only, studying Labor Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04303702 currently recruiting?
Yes, NCT04303702 is actively recruiting participants. Contact the research team at nraghuraman@wustl.edu for enrollment information.
Where is the NCT04303702 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT04303702 clinical trial?
NCT04303702 is sponsored by Washington University School of Medicine. The trial plans to enroll 400 participants.